Very recently, we reported profound inhibition of CD73 activity on B cells from patients with systemic lupus erythematosus (SLE) [18], which most likely was due to a yet unidentified post-translational modification of CD73. The gene discussed is NT5E; the disease is systemic lupus erythematosus.